Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson
Blood Cancer Talks
00:00
Funding complexities and outpatient treatments for refractory lymphoma
This chapter explores the complexities of funding and treatment models that affect the significance of certain treatments, with a focus on outpatient treatments for refractory lymphoma. It discusses the possibility of developing scoring systems for determining hospitalization needs and touches upon the topic of infections in patients receiving bispecific antibodies.
Transcript
Play full episode
